The US government is providing $176 million to Moderna to develop an mRNA-based pandemic influenza vaccine to prepare for potential bird flu threats, learning from the Covid pandemic.
Using mRNA technology for vaccine development, similar to Moderna's Covid jab, allows for faster production and potential quick response to mutating viruses like H5N1 avian influenza.
The goal is to tackle bird flu, a low current threat with potential severe consequences if it mutates and spreads to humans, by enhancing readiness and response capabilities.
[
add
]
[
|
|
...
]